Family

+

−

Country	kind	publication No.	Filing Date	Type	Sub-Type
WO	A1	WO2021155167	Jan 29, 2021	Patent	Application
Type : Patent Sub-Type : Application
INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT		BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES		Aug 05, 2021
EP	B1	EP4097119	Jan 29, 2021	Patent	Grant
Type : Patent Sub-Type : Grant
Patent		BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES		May 07, 2025
JP	A	JP2023513086	Jan 29, 2021	Patent	Application
Type : Patent Sub-Type : Application
Published unexamined patent application		炎症性疾患を処置するための胆汁酸－ＧＣＰＩＩ阻害剤コンジュゲート		Mar 30, 2023

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR V V I	FLEMINGOVO NAM 542/2 166 10 PRAGUE 6

International Classification(s)

• C07J:STEROIDS

• 2021 Application Filing Year
• C07J Class
• 136 Applications Filed
• 41 Patents Issued To-Date
• 30.15 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Majer, Pavel	Prague, CZ	38	153
# of filed Patents : 38 Total Citations : 153
Peters, Diane E	Baltimore, US	2	1
# of filed Patents : 2 Total Citations : 1
Rais, Rana	Baltimore, US	30	60
# of filed Patents : 30 Total Citations : 60
Slusher, Barbara	Baltimore, US	45	104
# of filed Patents : 45 Total Citations : 104
Snajdr, Ivan	Prague, CZ	8	6
# of filed Patents : 8 Total Citations : 6
Tenora, Lukas	Prague, CZ	15	35
# of filed Patents : 15 Total Citations : 35

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• C07J Class

• 0 % this patent is cited more than
• 2 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
3.5 Year Payment	$1600.00	$800.00	$400.00	Oct 27, 2026
7.5 Year Payment	$3600.00	$1800.00	$900.00	Oct 27, 2030
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Oct 27, 2034

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 3.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2023/0128,984

BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES, INCLUDING INFLAMMATORY BOWEL DISEASE (IBD)

---

Abstract

---

GCPII inhibitors comprising 2-(phosphonomethyl) pentanedioic acid (2-PMPA) conjugated to a bile acid and their use for treating a disease or condition associated with elevated levels of GCPII, including inflammatory bowel disease.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.